ProCE Banner Activity

Chronic Spontaneous Urticaria: Key Concepts in Diagnosis and Treatment

Clinical Thought

Chronic spontaneous urticaria (CSU) significantly impacts a patient’s physical and emotional health, and appropriate management is essential for improving quality of life.In this expert commentary, Jonathan A. Bernstein, MD provides an overview of key concepts regarding the diagnosis and treatment CSU.

Released: September 15, 2022

Expiration: September 14, 2023

Begin Activity

Share

Faculty

Jonathan Bernstein

Jonathan Bernstein, MD

Professor of Medicine
Division of Immunology, Rheumatology, and Allergy
Department of Internal Medicine
University of Cincinnati
Cincinnati, Ohio

Acknowledgement

This program is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc.; Incyte Corporation; Novartis Pharmaceuticals Corporation; and Sanofi and Regeneron Pharmaceuticals.

This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.

Provided by

ProCE Banner

Target Audience

Dermatologists and APPs and nurses who practice in dermatology.

Disclosure

Jonathan A. Bernstein, MD: consultant/advisor/speaker: AstraZeneca, Genentech, Novartis, Sanofi-Regeneron; research support: Allakos, AstraZeneca, Amgen, Celldex, Genentech, Sanofi-Regeneron, TLL.

Format

ClinicalThought

Additional Information

Program Medium

This program has been made available online.